Statera Biopharma Inc (STAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,590 | -13,045 | 35 | -20,129 | -22,415 |
| Depreciation Amortization | 64 | 275 | 841 | 471 | 480 |
| Accounts receivable | 301 | -414 | 629 | -417 | 1,736 |
| Accounts payable and accrued liabilities | 124 | -834 | 459 | -714 | 610 |
| Other Working Capital | 754 | -1,441 | 560 | -2,344 | 6,136 |
| Other Operating Activity | -3,692 | 3,379 | -16,980 | 29 | -7,196 |
| Operating Cash Flow | $-5,040 | $-12,080 | $-14,455 | $-23,103 | $-20,650 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 5,487 | -13,690 | 282 | 2,198 | 3,091 |
| PPE Investments | 189 | 6 | -20 | -140 | -178 |
| Net Acquisitions | N/A | 3,000 | -2,048 | N/A | N/A |
| Other Investing Activity | -3 | 407 | 0 | -1,498 | -1,541 |
| Investing Cash Flow | $5,673 | $-10,277 | $-1,787 | $561 | $1,372 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 7,328 | N/A |
| Debt Repayment | N/A | -2,672 | -4,260 | -78 | -52 |
| Common Stock Issued | 540 | 27,608 | 9,698 | 12 | 15,678 |
| Other Financing Activity | 0 | 0 | 5,152 | 0 | 5,894 |
| Financing Cash Flow | $540 | $24,936 | $10,590 | $7,262 | $21,519 |
| Exchange Rate Effect | -190 | 236 | -1,293 | -324 | 538 |
| Beginning Cash Position | 5,918 | 3,104 | 10,049 | 25,652 | 22,873 |
| End Cash Position | 6,902 | 5,918 | 3,104 | 10,049 | 25,652 |
| Net Cash Flow | $983 | $2,815 | $-6,945 | $-15,604 | $2,780 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,040 | -12,080 | -14,455 | -23,103 | -20,650 |
| Capital Expenditure | -10 | -20 | -20 | -140 | -178 |
| Free Cash Flow | -5,050 | -12,100 | -14,475 | -23,242 | -20,828 |